BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 23966620)

  • 1. Hsp90 inhibitors promote p53-dependent apoptosis through PUMA and Bax.
    He K; Zheng X; Zhang L; Yu J
    Mol Cancer Ther; 2013 Nov; 12(11):2559-68. PubMed ID: 23966620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blockade of Hsp90 by 17AAG antagonizes MDMX and synergizes with Nutlin to induce p53-mediated apoptosis in solid tumors.
    Vaseva AV; Yallowitz AR; Marchenko ND; Xu S; Moll UM
    Cell Death Dis; 2011 May; 2(5):e156. PubMed ID: 21562588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mode of cell death induced by the HSP90 inhibitor 17-AAG (tanespimycin) is dependent on the expression of pro-apoptotic BAX.
    Powers MV; Valenti M; Miranda S; Maloney A; Eccles SA; Thomas G; Clarke PA; Workman P
    Oncotarget; 2013 Nov; 4(11):1963-75. PubMed ID: 24185264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of Hsp90 via 17-DMAG induces apoptosis in a p53-dependent manner to prevent medulloblastoma.
    Ayrault O; Godeny MD; Dillon C; Zindy F; Fitzgerald P; Roussel MF; Beere HM
    Proc Natl Acad Sci U S A; 2009 Oct; 106(40):17037-42. PubMed ID: 19805107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purified vitexin compound 1, a new neolignan isolated compound, promotes PUMA-dependent apoptosis in colorectal cancer.
    Chen J; Zhong J; Liu Y; Huang Y; Luo F; Zhou Y; Pan X; Cao S; Zhang L; Zhang Y; Wang J
    Cancer Med; 2018 Dec; 7(12):6158-6169. PubMed ID: 30402948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic genetic dissection of p14ARF-mediated mitochondrial cell death signaling reveals a key role for p21CDKN1 and the BH3-only protein Puma/bbc3.
    Hemmati PG; Müer A; Gillissen B; Overkamp T; Milojkovic A; Wendt J; Dörken B; Daniel PT
    J Mol Med (Berl); 2010 Jun; 88(6):609-22. PubMed ID: 20419447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HSP90 inhibitor enhances anti-proliferative and apoptotic effects of celecoxib on HT-29 colorectal cancer cells via increasing BAX/BCL-2 ratio.
    Mohammadi A; Yaghoobi MM; GholamhoseynianNajar A; Kalantari-Khandani B; Sharifi H; Saravani M
    Cell Mol Biol (Noisy-le-grand); 2016 Oct; 62(12):62-67. PubMed ID: 27894402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of HSP90 by AUY922 Preferentially Kills Mutant KRAS Colon Cancer Cells by Activating Bim through ER Stress.
    Wang CY; Guo ST; Wang JY; Liu F; Zhang YY; Yari H; Yan XG; Jin L; Zhang XD; Jiang CC
    Mol Cancer Ther; 2016 Mar; 15(3):448-59. PubMed ID: 26832792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. P53-dependent radiosensitizing effects of Hsp90 inhibitor 17-allylamino-17-demethoxygeldanamycin on human oral squamous cell carcinoma cell lines.
    Shintani S; Zhang T; Aslam A; Sebastian K; Yoshimura T; Hamakawa H
    Int J Oncol; 2006 Nov; 29(5):1111-7. PubMed ID: 17016641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-cancer effects of JKA97 are associated with its induction of cell apoptosis via a Bax-dependent and p53-independent pathway.
    Luo W; Liu J; Li J; Zhang D; Liu M; Addo JK; Patil S; Zhang L; Yu J; Buolamwini JK; Chen J; Huang C
    J Biol Chem; 2008 Mar; 283(13):8624-33. PubMed ID: 18218619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combining trail with PI3 kinase or HSP90 inhibitors enhances apoptosis in colorectal cancer cells via suppression of survival signaling.
    Saturno G; Valenti M; De Haven Brandon A; Thomas GV; Eccles S; Clarke PA; Workman P
    Oncotarget; 2013 Aug; 4(8):1185-98. PubMed ID: 23852390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting GRP75 improves HSP90 inhibitor efficacy by enhancing p53-mediated apoptosis in hepatocellular carcinoma.
    Guo W; Yan L; Yang L; Liu X; E Q; Gao P; Ye X; Liu W; Zuo J
    PLoS One; 2014; 9(1):e85766. PubMed ID: 24465691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 6-Hydroxydopamine activates the mitochondrial apoptosis pathway through p38 MAPK-mediated, p53-independent activation of Bax and PUMA.
    Gomez-Lazaro M; Galindo MF; Concannon CG; Segura MF; Fernandez-Gomez FJ; Llecha N; Comella JX; Prehn JH; Jordan J
    J Neurochem; 2008 Mar; 104(6):1599-612. PubMed ID: 17996028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of p53, PUMA, and Bax in wogonin-induced apoptosis in human cancer cells.
    Lee DH; Kim C; Zhang L; Lee YJ
    Biochem Pharmacol; 2008 May; 75(10):2020-33. PubMed ID: 18377871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined effect of Hsp90 inhibitor geldanamycin and parthenolide via reactive oxygen species-mediated apoptotic process on epithelial ovarian cancer cells.
    Lee CS; Kim YJ; Lee SA; Myung SC; Kim W
    Basic Clin Pharmacol Toxicol; 2012 Sep; 111(3):173-81. PubMed ID: 22433057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crizotinib induces PUMA-dependent apoptosis in colon cancer cells.
    Zheng X; He K; Zhang L; Yu J
    Mol Cancer Ther; 2013 May; 12(5):777-86. PubMed ID: 23427294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53-Dependent p21-mediated growth arrest pre-empts and protects HCT116 cells from PUMA-mediated apoptosis induced by EGCG.
    Thakur VS; Ruhul Amin AR; Paul RK; Gupta K; Hastak K; Agarwal MK; Jackson MW; Wald DN; Mukhtar H; Agarwal ML
    Cancer Lett; 2010 Oct; 296(2):225-32. PubMed ID: 20444544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A coordinated action of Bax, PUMA, and p53 promotes MG132-induced mitochondria activation and apoptosis in colon cancer cells.
    Ding WX; Ni HM; Chen X; Yu J; Zhang L; Yin XM
    Mol Cancer Ther; 2007 Mar; 6(3):1062-9. PubMed ID: 17363499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HSP90 inhibitors enhance differentiation and MITF (microphthalmia transcription factor) activity in osteoclast progenitors.
    van der Kraan AG; Chai RC; Singh PP; Lang BJ; Xu J; Gillespie MT; Price JT; Quinn JM
    Biochem J; 2013 Apr; 451(2):235-44. PubMed ID: 23379601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pazopanib, a novel multi-kinase inhibitor, shows potent antitumor activity in colon cancer through PUMA-mediated apoptosis.
    Zhang L; Wang H; Li W; Zhong J; Yu R; Huang X; Wang H; Tan Z; Wang J; Zhang Y
    Oncotarget; 2017 Jan; 8(2):3289-3303. PubMed ID: 27924057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.